These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3328677)

  • 1. [Management of refractory and fulminating colitis].
    Turunen U
    Duodecim; 1987; 103(14):890-6. PubMed ID: 3328677
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term therapy in ulcerative colitis and Crohn's disease].
    Malchow H
    Fortschr Med; 1979 Aug; 97(29):1253-60. PubMed ID: 457018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U; Maier K; Fischer C; Heinkel K
    N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New therapeutic data in inflammatory colitis].
    Karsenti P
    Ann Gastroenterol Hepatol (Paris); 1996; 32(1):10. PubMed ID: 8669802
    [No Abstract]   [Full Text] [Related]  

  • 5. [Crohn's disease. Has there been progress in its treatment?].
    Berenguer J
    Med Clin (Barc); 1984 Jun; 83(2):61-4. PubMed ID: 6147447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 7. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
    Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active therapeutic moiety of sulphasalazine.
    van Hees PA; van Tongeren JH; Bakker JH; van Lier HJ
    Lancet; 1978 Feb; 1(8058):277. PubMed ID: 74700
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Aminosalicylic acid for the treatment of inflammatory bowel disease.
    Dew MJ; Evans BK; Rhodes J
    Gastroenterology; 1984 Aug; 87(2):480-1. PubMed ID: 6735091
    [No Abstract]   [Full Text] [Related]  

  • 11. IBD: which 5-ASA drug works where?
    Ferry GD
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):474-5. PubMed ID: 8315560
    [No Abstract]   [Full Text] [Related]  

  • 12. [5-Aminosalicylic acid -- a new therapeutic possibility in chronic inflammatory intestinal disease?].
    Roth W
    Leber Magen Darm; 1986 May; 16(3):176-8. PubMed ID: 3736310
    [No Abstract]   [Full Text] [Related]  

  • 13. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease].
    Hartmann F
    Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical management of specific clinical presentations.
    Bitton A; Peppercorn MA
    Gastroenterol Clin North Am; 1995 Sep; 24(3):541-58. PubMed ID: 8809235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J
    Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesalazine in Crohn disease].
    Linnestad P
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3252. PubMed ID: 2256041
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will there be a next generation of sulfasalazine?
    Goldman P
    Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inflammatory bowel diseases].
    Kruis W
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S73-5. PubMed ID: 15368174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic inflammatory intestinal diseases in childhood].
    Binder V
    Ugeskr Laeger; 1978 Jul; 140(30):1831-2. PubMed ID: 695046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.